ClassID:

20918

A61K38/1709 - page 14 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#3901
20110224287
2011-09-15

AUGMENTED COGNITIVE TRAINING

#3902
20110224279
2011-09-15

ANTICANCER AGENT

#3903
20110224146
2011-09-15

Augmented cognitive training

#3904
20110224132
2011-09-15

Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases

#3905
20110223145
2011-09-15

IMMUNOSUPPRESSIVE BLOOD CELLS AND METHODS OF PRODUCING THE SAME

#3906
20110223138
2011-09-15

Mesenchymal stem cells that express increased amounts of anti-apoptotic proteins

#3907
20110223133
2011-09-15

Therapeutic agent for hematopoietic tumors

#3908
20110217733
2011-09-08

Expanding the eukaryotic genetic code

#3909
20110217724
2011-09-08

METHOD OF PROTECTING CELLS

#3910
20110217389
2011-09-08

Methods for treating heat stress and related compositions

#3911
20110217264
2011-09-08

METHODS AND COMPOSITIONS FOR DELIVERY OF EXOGENOUS FACTORS TO NERVIOUS SYSTEM SITES

#3912
20110213328
2011-09-01

Methods and Systems for Treatment of Neurological Diseases of the Central Nervous System

#3913
20110212897
2011-09-01

WNT3A FOR INHIBITION OF SCARRING

#3914
20110212886
2011-09-01

Pharmaceutical compositions comprising casein derived peptides and methods of use thereof

#3915
20110212885
2011-09-01

OPHTHALMIC AND CONTACT LENS SOLUTIONS CONTAINING PEPTIDES AS PRESERVATIVE

#3916
20110212139
2011-09-01

High-density lipoprotein coated medical devices

#3917
20110212131
2011-09-01

METHOD FOR ENHANCING AN IMMUNE RESPONSE

#3918
20110212081
2011-09-01

KRÜPPEL-LIKE FACTORS AND FAT REGULATION

#3919
20110212075
2011-09-01

SCREENING METHOD FOR POLYMORPHIC MARKERS IN HTRA1 GENE IN NEURODEGENERATIVE DISORDERS

#3920
20110207657
2011-08-25

Selectively targeted antimicrobial peptides and the use thereof

#3921
20110202033
2011-08-18

COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CARDIAC ISCHEMIC INJURY

#3922
20110201987
2011-08-18

COMBINATION THERAPY FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE, AND KIT THEREFOR

#3923
20110201548
2011-08-18

THERAPEUTIC AGENT FOR ACUTE HEPATITIS OR PROPHYLACTIC/THERAPEUTIC AGENT FOR FULMINANT HEPATITIS

#3924
20110201542
2011-08-18

Myeloid protein activation of anti-inflammatory and anti-hypoxic pathway

#3925
20110201105
2011-08-18

LACTATION-ASSOCIATED POLYPEPTIDES

#3926
20110200592
2011-08-18

Methods for inhibiting HIV-1 replication involving the administration of an anti-CCR5 receptor monoclonal antibody and small molecule CCR5 receptor antagonist

#3927
20110200564
2011-08-18

DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE (AD)

#3928
20110195905
2011-08-11

APLS FOR TREATING ARTHRITIS

#3929
20110195893
2011-08-11

Use of apolipoproteins to decrease inflammation

#3930
20110195073
2011-08-11

COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE

#3931
20110191871
2011-08-04

METHODS TO IDENTIFY FACTORS ASSOCIATED WITH MUSCLE GROWTH AND USES THEREOF

#3932
20110190730
2011-08-04

METHODS OF INDUCING PLURIPOTENCY INVOLVING OCT4 PROTEIN

#3933
20110190729
2011-08-04

METHODS OF INDUCING PLURIPOTENCY INVOLVING SOX2 PROTEIN

#3934
20110190350
2011-08-04

Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit

#3935
20110190207
2011-08-04

Inhibiting binding of FGF23 to the binary FGFR-Klotho complex for the treatment of hypophosphatemia

#3936
20110190193
2011-08-04

Treatment of endothelial dysfunction in diabetic patients

#3937
20110190192
2011-08-04

METHODS FOR TREATING ERECTILE DYSFUNCTION IN PATIENTS WITH INSULIN-DEPENDENT DIABETES

#3938
20110189731
2011-08-04

Polynucleotides encoding recombinant lubricin molecules and uses thereof

#3939
20110189205
2011-08-04

Methods of treating cancer using the calcitonin-gene related peptide (“CGRP”) receptor antagonist CGRP8-37

#3940
20110189199
2011-08-04

METHODS FOR P2RY5 MEDIATED REGULATION OF HAIR GROWTH AND MUTANTS THEREOF

#3941
20110189175
2011-08-04

Chronic lymphocytic leukemia prognosis and treatment

#3942
20110189105
2011-08-04

Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use

#3943
20110183915
2011-07-28

Small molecule cancer treatments that cause necrosis in cancer cells but do not affect normal cells

#3944
20110183911
2011-07-28

METHOD FOR IMPROVING NEUROTRANSMISSION FAILURE USING A NOVEL AGENT

#3945
20110183910
2011-07-28

Biglycan and related therapeutics and methods of use

#3946
20110183909
2011-07-28

Treatment of mood and anxiety disorders

#3947
20110183890
2011-07-28

Methods for modulating angiogenesis via dystrophin Dp71

#3948
20110183887
2011-07-28

Methods and compositions for the reduction of neutrophil influx and the treatment of bronchopulmonary displasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease

#3949
20110182992
2011-07-28

PEPTIDES AND PEPTIDE MIMETICS TO TREAT PATHOLOGIES ASSOCIATED WITH EYE DISEASE

#3950
20110182989
2011-07-28

Peptide compositions and therapeutic uses thereof

#3951
20110182822
2011-07-28

Biomarkers for painful intervertebral discs and methods of use thereof

#3952
20110179509
2011-07-21

Use of Afamin for Treating Fertility Disorders

#3953
20110178160
2011-07-21

Inhibition of interaction of PSD93 and PSDS95 with nNOS and NMDA receptors

#3954
20110178023
2011-07-21

Use Of SCO-Spondin Peptides For Inhibiting Or Preventing Neuronal Apoptosis Mediated By Cell Death Receptor Ligands

#3955
20110178021
2011-07-21

OPIORPHIN FOR USE AS A PSYCHOSTIMULANT AGENT

#3956
20110177543
2011-07-21

Regulation of BACE degradation

#3957
20110177040
2011-07-21

Cytokine induction of selectin ligands on cells

#3958
20110172144
2011-07-14

METHODS FOR INCREASING EXPRESSION OF SERCA2A IN CARDIAC MUSCLE

#3959
20110171238
2011-07-14

NOVEL STRA6 POLYPEPTIDES

#3960
20110171211
2011-07-14

Heat shock protein GP96 vaccination and methods of using same

#3961
20110171207
2011-07-14

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION AND AUTO-IMMUNE DISEASES

#3962
20110171179
2011-07-14

Method for Regulating Production of Hemoglobin Beta Chains

#3963
20110171178
2011-07-14

Compositions and methods of using proislet peptides and analogs thereof

#3964
20110166178
2011-07-07

Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase

#3965
20110166145
2011-07-07

Stabilization of hypoxia inducible factor (HIF) alpha

#3966
20110165173
2011-07-07

THERAPEUTIC AGENT AND DETECTION REAGENT FOR ARTERIOSCLEROTIC DISEASE WHICH TARGETS FOR SALUSIN

#3967
20110165138
2011-07-07

PROTOCOLS FOR TREATING AND PREVENTING OBESITY AND COMPLICATIONS ARISING THEREFROM

#3968
20110165131
2011-07-07

METHODS FOR TREATING DISEASES AND INCREASING LONGEVITY

#3969
20110165081
2011-07-07

PSMA antibodies and uses thereof

#3970
20110162092
2011-06-30

COMPOSITION COMPRISED OF AKAP12 AND USES OF AKAP12 MUTANT ZEBRAFISH AS AN ANIMAL MODEL

#3971
20110160142
2011-06-30

Alpha B-crystallin as a therapy for multiple sclerosis

#3972
20110160118
2011-06-30

METHODS AND COMPOSITIONS FOR TREATING ORAL AND ESOPHAGEAL LESIONS

#3973
20110159588
2011-06-30

Methods for Modulating a PDGF-AA Mediated Biological Response

#3974
20110159131
2011-06-30

USE OF STRAINS OF LACTOBACILLUS AND BY-PRODUCTS THEREOF FOR INHIBITING FORMATION OF BLOOD VESSELS

#3975
20110159112
2011-06-30

Recombinant alpha-fetoprotein and compositions thereof

#3976
20110159034
2011-06-30

METHODS AND REAGENTS FOR VACCINATION WHICH GENERATE A CD8 T CELL IMMUNE RESPONSE

#3977
20110151539
2011-06-23

USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF

#3978
20110151016
2011-06-23

Use of angiogenin or angiogenin agonists for treating diseases and disorders

#3979
20110150875
2011-06-23

Method of reducing total cholesterol level by administering matrilin-2 polypeptide

#3980
20110150769
2011-06-23

IDENTIFICATION AND USE OF COMPOUNDS FOR TREATING PERSISTENT PAIN

#3981
20110144718
2011-06-16

Composition and method for the treatment or prevention of spinal disorders

#3982
20110144306
2011-06-16

LIGATION OF STAPLED POLYPEPTIDES

#3983
20110144036
2011-06-16

Method for using HIP/PAP polypeptide composition for liver regeneration and prevention of liver failure

#3984
20110144031
2011-06-16

Pharmaceutical composition for inducing damages of endothelial cells and treating tumor and method for treating tumor by using the same

#3985
20110143436
2011-06-16

Compositions and methods for reprogramming eukaryotic cells

#3986
20110142908
2011-06-16

Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication

#3987
20110142795
2011-06-16

METHODS OF TREATING COGNITIVE IMPAIRMENT

#3988
20110136895
2011-06-09

Methods and compositions for modulating PD1

#3989
20110136732
2011-06-09

INFANT NUTRITIONAL COMPOSITIONS FOR PREVENTING OBESITY

#3990
20110135660
2011-06-09

PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC DISEASE

#3991
20110135652
2011-06-09

Use of Idbf

#3992
20110135638
2011-06-09

ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy

#3993
20110130345
2011-06-02

ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES FOR TREATING AGE-RELATED MACULAR DEGENERATION

#3994
20110130326
2011-06-02

DEFENSINS FOR TREATMENT OF INFECTIVE ENDOCARDITIS

#3995
20110130325
2011-06-02

Apoptosis-modulating p53 protein therapy for vascular disorders and nanoparticles containing the same

#3996
20110129526
2011-06-02

COMPOSITIONS AND METHODS FOR TREATING VASCULAR DISEASE

#3997
20110129484
2011-06-02

Immunotherapies employing self-assembling vaccines

#3998
20110124580
2011-05-26

REGULATION OF LUNG TISSUE BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO

#3999
20110124568
2011-05-26

Use of heat-shock protein 27 for cardiovascular disease prevention and treatment

#4000
20110123553
2011-05-26

Use of LINGO-4 Antagonists in the Treatment of Conditions Involving Demyelination

#4001
20110123534
2011-05-26

NOVEL COMPOUNDS FOR MODULATING NEOVASCULARISATION AND METHODS OF TREATMENT USING THESE COMPOUNDS

#4002
20110123484
2011-05-26

METHODS AND COMPOSITIONS FOR TREATING FUS1 RELATED DISORDERS

#4003
20110123454
2011-05-26

Method for modulating appetite

#4004
20110118193
2011-05-19

TREATMENT OF LIQUID CANCERS

#4005
20110117049
2011-05-19

Methods and compositions for modulating adipocyte function

#4006
20110112280
2011-05-12

USE OF RGM AND ITS MODULATORS

#4007
20110112016
2011-05-12

Compositions and methods for modulating the immune system

#4008
20110112015
2011-05-12

USE OF GLIS3 FOR PREPARING FUNCTIONAL PANCREATIC BETA-CELLS

#4009
20110111405
2011-05-12

Novel genes and markers in type 2 diabetes and obesity

#4010
20110111404
2011-05-12

Novel genes and markers in type 2 diabetes and obesity

#4011
20110105570
2011-05-05

Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit

#4012
20110105569
2011-05-05

Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit

#4013
20110105407
2011-05-05

Tissue inhibitor of metalloproteinases (TIMP) linked to glycosylphosphatidylinositol (GPI)-anchors for treatment of cancer and skin lesions

#4014
20110105405
2011-05-05

METHOD FOR ALLEVIATING PAIN USING PROTEIN ASSOCIATED WITH MYC AND RELATED COMPOUNDS, AND ASSAYS FOR IDENTIFYING SUCH COMPOUNDS

#4015
20110104252
2011-05-05

ANTI-APOPTOTIC GENE SCC-S2 AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF

#4016
20110104217
2011-05-05

Method of treating an ischemia-reperfusion injury-related disorder by administering GPCR ligands

#4017
20110104146
2011-05-05

Method of inhibiting platelet aggregation and clot formation

#4018
20110104138
2011-05-05

USE OF THE INNATE IMMUNITY GENE OASL FOR PREVENTING OR TREATING INFECTION WITH NEGATIVE STRAND RNA VIRUSES

#4019
20110104127
2011-05-05

mRNA-TRANSFECTION OF ADULT PROGENITOR CELLS FOR SPECIFIC TISSUE REGENERATION

#4020
20110104118
2011-05-05

COMPOSITIONS AND METHODS FOR THERAPEUTIC USE

#4021
20110098345
2011-04-28

Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics

#4022
20110098216
2011-04-28

THERAPEUTIC USES OF COLOSTRININ

#4023
20110097309
2011-04-28

Pharmaceutical Agent for Promoting the Functional Regeneration of Damaged Tissue

#4024
20110097300
2011-04-28

Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis

#4025
20110092434
2011-04-21

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders

#4026
20110092430
2011-04-21

METHOD AND COMPOUND FOR THE TREATMENT OF VALVULAR DISEASE

#4027
20110092416
2011-04-21

Vitamine B12 - Peptide Conjugates for Oral Delivery

#4028
20110092414
2011-04-21

Composition for treating virus infection disease comprising Jab1

#4029
20110091928
2011-04-21

Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation

#4030
20110091527
2011-04-21

Compositions and methods for reducing scar formation in wound healing

#4031
20110091469
2011-04-21

ATTRACTIN/MAHOGANY-LIKE POLYPEPTIDES, POLYNUCLEOTIDES, ANTIBODIES AND METHODS OF USE THEREOF

#4032
20110091464
2011-04-21

Proteins and methods for modulating cell activity

#4033
20110091460
2011-04-21

Receptor-targeting reagents containing epidermal factor receptor-binding agents and IL-13 receptor-binding agents or IL-4 receptor-binding agents

#4034
20110091437
2011-04-21

FUSION PROTEINS

#4035
20110091427
2011-04-21

METHODS FOR TREATING A KIDNEY INJURY

#4036
20110086807
2011-04-14

Fibromodulin formulation for reducing corneal scarring

#4037
20110086802
2011-04-14

METHODS TO INCREASE PERMEABILITY OF CORNEAL EPITHELIUM AND DESTABILIZE STROMAL COLLAGEN FIBRIL NETWORK

#4038
20110086068
2011-04-14

Compositions and methods for tissue engineering, tissue regeneration and wound healing

#4039
20110086055
2011-04-14

Chimeric peptides comprising HER-2 B-cell epitopes and T-helper epitopes

#4040
20110086044
2011-04-14

Compositions and Methods to Inhibit HPV Infection

#4041
20110086043
2011-04-14

STAT5a and its functional tumor suppressor analogs for treatment of malignancies expressing NPM/ALK and other oncogenic kinases

#4042
20110086020
2011-04-14

Agent exhibiting immunoregulatory properties and the use thereof for treating autoimmune diseases

#4043
20110086002
2011-04-14

Restoration of hearing loss

#4044
20110082093
2011-04-07

Engineered zinc finger proteins for treating trinucleotide repeat disorders

#4045
20110082072
2011-04-07

Method of inhibiting inflammation in a mammal by administering Bcl protein

#4046
20110081403
2011-04-07

HISTONE OCTAMERS FOR INCREASED NUCLEIC ACID TRANSFER

#4047
20110077702
2011-03-31

Means and Methods for Influencing Electrical Activity of Cells

#4048
20110077206
2011-03-31

USE OF HNF4ALPHA FOR TREATMENT OF HUMAN MALIGNANT SOLID TUMORS THROUGH INDUCTION-DIFFERENTIATION THERAPY

#4049
20110076342
2011-03-31

Cell proliferation reducing cancer specific PCNA peptides

#4050
20110071088
2011-03-24

Method for treating stroke via administration of NEP1-40 and inosine

#4051
20110071086
2011-03-24

COMPOSITIONS FOR TISSUE REPAIR/REGENERATION

#4052
20110071085
2011-03-24

USE OF SURVIVIN TO TREAT KIDNEY FAILURE

#4053
20110070236
2011-03-24

Use of immunesuppressant receptor

#4054
20110070234
2011-03-24

NP1 ACTIVITY REGULATING ELEMENTS USEFUL FOR THE PRODUCTION OF DRUGS FOR THE TREATMENT OR PREVENTION OF HUMAN NEURODEGENERATIVE DISEASES, RESULTING DRUGS AND USE THEREOF

#4055
20110070222
2011-03-24

Therapeutic modulation of ocular surface lubrication

#4056
20110065650
2011-03-17

Methods of inhibiting tumor cell proliferation

#4057
20110065646
2011-03-17

Methods of reducing excitotoxicity-induced retinal ganglionic neuron degeneration by an orthodenticle HOMOLOG2 (OTX2) homeoprotein

#4058
20110064792
2011-03-17

Method for opening tight junctions

#4059
20110060120
2011-03-10

IMMUNOGENIC TREATMENT OF CANCER BY PEPTIDES INDUCING THE PLASMA MEMBRANE EXPOSURE OF ERP57

#4060
20110059902
2011-03-10

Compositions for treating dry eye disease

#4061
20110059173
2011-03-10

Compositions and methods for promoting wound healing and tissue regeneration

#4062
20110059088
2011-03-10

Protein involved in ovarian cancer

#4063
20110053854
2011-03-03

Treatment of muscular dystrophies and related disorders

#4064
20110053852
2011-03-03

USE OF PODOCAN PROTEIN IN TREATING CARDIOVASCULAR DISEASES

#4065
20110053850
2011-03-03

Filipil compositions and methods for treating cancer

#4066
20110053848
2011-03-03

Prodrug comprising a drug linker conjugate

#4067
20110053217
2011-03-03

Polynucleotides encoding signal peptide-containing molecules

#4068
20110052625
2011-03-03

COMPOSITIONS AND METHODS FOR TREATING DIABETES USING LISOFYLLINE ANALOGS AND ISLET NEOGENESIS ASSOCIATED PEPTIDE

#4069
20110052563
2011-03-03

GONADAL FUNCTION IMPROVING AGENTS

#4070
20110052531
2011-03-03

Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy

#4071
20110052498
2011-03-03

Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders

#4072
20110046538
2011-02-24

Combination of a light ray with a cytochrome C oxidase substrate particularly for improving the appearance of the skin and/or hair

#4073
20110046068
2011-02-24

Compound, use and method

#4074
20110046038
2011-02-24

Polypeptide-polymer conjugates and methods of use thereof

#4075
20110044970
2011-02-24

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DRY EYE

#4076
20110044956
2011-02-24

NELL-1 ENHANCED BONE MINERALIZATION

#4077
20110044947
2011-02-24

METHODS OF TREATING CARDIAC DISORDERS

#4078
20110044893
2011-02-24

Vascular targets for detecting, imaging and treating neoplasia or neovasculature

#4079
20110039788
2011-02-17

COMPOSITIONS, METHODS AND KITS FOR DETECTING AND TREATING CANCER

#4080
20110039776
2011-02-17

FUSION PEPTIDE THERAPEUTIC COMPOSITIONS

#4081
20110039335
2011-02-17

Compositions and methods for inhibiting cell migration

#4082
20110038880
2011-02-17

PARASPORIN-1 RECEPTOR AND USE THEREOF

#4083
20110038851
2011-02-17

Treatment of synucleinopathies

#4084
20110038831
2011-02-17

Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators

#4085
20110034533
2011-02-10

Compositions and methods modulating MG29 for the treatment of diabetes

#4086
20110034389
2011-02-10

ACTIVE AGENTS, COMPOSITIONS, AND METHODS FOR INHIBITING AND REVERSING PLATELET FUNCTION

#4087
20110034372
2011-02-10

Truncated activin type II receptor and methods of use

#4088
20110033516
2011-02-10

METHODS AND COMPOSITIONS FOR BONE HEALING BY PERIOSTIN

#4089
20110033488
2011-02-10

AGENTS AND METHODS FOR TREATMENT OF ANXIETY DISORDERS

#4090
20110033479
2011-02-10

PROTEINS EZRIN, SERPIN B5, PEROXIREDOXIN-2 AND HEAT SHOCK PROTEIN BETA-1 AS AUTOANTIGENS FOR PSORIASIS VULGARIS AND POSTSTREPTOCOCCAL DISEASES

#4091
20110033438
2011-02-10

Method and pharmacological composition for the diagnosis and treatment of male

#4092
20110033414
2011-02-10

Cardiovascular therapy compositions

#4093
20110028536
2011-02-03

METHODS AND COMPOSITIONS FOR TOPOISOMERASE I MODULATED TUMOR SUPPRESSION

#4094
20110028398
2011-02-03

METHODS FOR TREATING AND LIMITING FIBROTIC DISORDERS AND KELOIDS

#4095
20110028387
2011-02-03

METHODS OF SCREENING OF PP1-INTERACTING POLYPEPTIDES OR PROTEINS, PEPTIDES INHIBITING PP1c BINDING TO Bcl-2 PROTEINS, BCL-XL AND BCL-W, AND USES THEREOF

#4096
20110021605
2011-01-27

MEANS AND METHODS FOR THE SPECIFIC INHIBITION OF GENES IN CELLS AND TISSUE OF THE CNS AND/OR EYE

#4097
20110021441
2011-01-27

Conjugate comprising P21 protein for the treatment of cancer

#4098
20110021440
2011-01-27

APOPTOTIC PATHWAY TARGETING FOR THE DIAGNOSIS AND TREATMENT OF CANCER

#4099
20110021433
2011-01-27

METHODS FOR TREATING OR PREVENTING HEART FAILURE

#4100
20110021432
2011-01-27

Manufacture of factor H (FH) and FH-derivatives from plasma

#4101
20110021422
2011-01-27

Method and compositions for prevention and treatment of diabetic and aged skin

#4102
20110021418
2011-01-27

ENRICHED HAPTOGLOBIN POLYMERS FOR THE TREATMENT OF DISEASE

#4103
20110021413
2011-01-27

Methods of suppressing microglial activation

#4104
20110020437
2011-01-27

Oligopeptidic compounds and uses thereof

#4105
20110020432
2011-01-27

COMPOSITIONS AND METHODS OF USE FOR POST-RADIATION PROTECTION

#4106
20110020431
2011-01-27

Antitumor effect of mutant Bik

#4107
20110020411
2011-01-27

Cystinosin replacement factor

#4108
20110020362
2011-01-27

Adrenergic stimulation mediates hypersensitivity by inducing nerve growth factor expression

#4109
20110020359
2011-01-27

METHODS AND COMPOSITIONS FOR TREATING NEURONAL DAMAGE OR DEGENERATION

#4110
20110020348
2011-01-27

PHARMACEUTICAL COMPOSITIONS AND METHODS USING SECRETED FRIZZLED RELATED PROTEIN

#4111
20110020321
2011-01-27

Method of inhibiting binding or activity of MIF by administering a MIF antagonist

#4112
20110020311
2011-01-27

Therapy of neurological inflammatory diseases with (5'-deoxy-5'-adenosyl) cobamamide, recombinant human growth hormone, interleukins IL-1, IL-6, IL-11, epidermal growth factor, and physiotherapy

#4113
20110020296
2011-01-27

METHODS FOR TREATING DISEASES AND INCREASING LONGEVITY

#4114
20110020295
2011-01-27

Pre-transplant accomodated organs resistant to anti-donor immunity

#4115
20110020282
2011-01-27

RECOMBINANT NEWCASTLE DISEASE VIRUS

#4116
20110020237
2011-01-27

Compositions and Methods for Inhibiting Drusen Formation and for Diagnosing or Treating Drusen-Related Disorders

#4117
20110017201
2011-01-27

Simple design to make solar water heating affordable and compatible with conventional water heaters

#4118
20110015252
2011-01-20

Lipid formulated dsRNA targeting the PCSK9 gene

#4119
20110015131
2011-01-20

METHODS FOR PREVENTING AND TREATING ALZHEIMER'S DISEASE (AD)

#4120
20110015123
2011-01-20

Modulation of GLUT4 Gene Promoter activity BY AHNAK

#4121
20110014279
2011-01-20

BIOACTIVE COMPLEX COMPOSITIONS AND METHODS OF USE THEREOF

#4122
20110014270
2011-01-20

PREVENTION AND TREATMENT OF ISCHEMIA-REPERFUSION INJURY AND RELATED CONDITIONS

#4123
20110014217
2011-01-20

Carbon nanotube compositions and methods of use thereof

#4124
20110014128
2011-01-20

CYTOKINE RECEPTOR MODULATORS, METHOD OF IDENTIFYING SAME, AND METHOD OF MODULATING CYTOKINE RECEPTORS ACTIVITY WITH SAME

#4125
20110008370
2011-01-13

Use of FLJ25416 gene

#4126
20110008349
2011-01-13

Hypoxia induced mitogenic factor

#4127
20110008302
2011-01-13

Compositions and methods for immortalizing cells and screening for anti-cancer agents

#4128
20110008281
2011-01-13

Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia

#4129
20110008278
2011-01-13

MODULATORS OF PARAPTOSIS AND RELATED METHODS

#4130
20110008269
2011-01-13

Compositions and methods which modulate G-protein signaling for the treatment of inflammatory disorders such as asthma and allergic conjunctivitis

#4131
20110003743
2011-01-06

STEM CELL DERIVED FACTORS FOR TREATING PATHOLOGIC CONDITIONS

#4132
20110003013
2011-01-06

METHOD OF INCREASING METABOLISM

#4133
20110002894
2011-01-06

Compositions and methods for treating and preventing heart tissue degeneration and uses thereof

#4134
20110002852
2011-01-06

STEM CELLS FOR USE IN LOCATING AND TARGETING TUMOR CELLS

#4135
20100331395
2010-12-30

Decoy-containing pharmaceutical compositions and method of using the same

#4136
20100331248
2010-12-30

COMPOSITIONS AND METHODS FOR TREATING DIABETES USING LISOFYLLINE AND ISLET NEOGENESIS ASSOCIATED PEPTIDE

#4137
20100331238
2010-12-30

Methods of screening for a compound that reduces atherogenesis

#4138
20100330097
2010-12-30

PREDICTING AMD WITH SNPS WITHIN OR NEAR C2, FACTOR B, PLEKHA1, HTRA1, PRELP, OR LOC387715

#4139
20100330062
2010-12-30

KLOTHO PROTEIN AND RELATED COMPOUNDS FOR THE TREATMENT AND DIAGNOSIS OF CANCER

#4140
20100329987
2010-12-30

Uses of Sperm Membrane Protein OBF

#4141
20100324154
2010-12-23

ASSESSING SUSCEPTIBILITY TO VASCULAR DISORDERS

#4142
20100324120
2010-12-23

Lipid formulation

#4143
20100323971
2010-12-23

Cell permeable Nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same

#4144
20100317601
2010-12-16

Casein Derived Peptides And Uses Thereof

#4145
20100317598
2010-12-16

Isolated BRCA1 peptides and method of use

#4146
20100317590
2010-12-16

Regulation of skin characteristics by DICKKOPF1 (DKK1)

#4147
20100317565
2010-12-16

Novel Peptides and Their Use for the Treatment of Edema

#4148
20100316602
2010-12-16

Compositions and methods for treatment of angiogenesis in pathological lesions

#4149
20100310575
2010-12-09

Inhibitors of Caspase I-Dependent Cytokines in the Treatment of Neurodegenerative Disorders

#4150
20100310524
2010-12-09

Compositions suitable for treatment of spinal disease, disorder or condition

#4151
20100310508
2010-12-09

Methods of treatment using a vector encoding p21/

#4152
20100310458
2010-12-09

Use of soluble CEACAM8 for diagnosing, treating or monitoring diseases, and a method for screening compounds that prevent apoptosis

#4153
20100305029
2010-12-02

Paralytic peptide for use as a insecticide

#4154
20100305024
2010-12-02

Methods of inhibiting calcineurin with ApoE analogs

#4155
20100303894
2010-12-02

treatment

#4156
20100303832
2010-12-02

GENES AND POLYMORPHISMS ASSOCIATED WITH AMD

#4157
20100303773
2010-12-02

Method of selecting stem cells having high chondrogenic differentiation capability

#4158
20100299769
2010-11-25

Methods to treat symptoms of pathophysiology related to body mass

#4159
20100298222
2010-11-25

Use of an agent that restores tissue perfusion and oxygenation

#4160
20100298216
2010-11-25

Casein Derived Peptides And Uses Thereof in Therapy

#4161
20100298215
2010-11-25

Synthetic apolipoprotein E mimicking polypeptides and methods of use

#4162
20100298202
2010-11-25

BRI POLYPEPTIDES AND REDUCING AB AGGREGATION

#4163
20100297150
2010-11-25

DISEASE TREATMENT VIA ANTIMICROBIAL PEPTIDE INHIBITORS

#4164
20100292309
2010-11-18

INDUCING IMMUNE-MEDIATED TUMOR CELL DEATH

#4165
20100292200
2010-11-18

Methods for Modulating Apoptosis in Platelets

#4166
20100292181
2010-11-18

COMPOSITIONS AND METHODS FOR DETECTING AND TREATING HIV INFECTIONS

#4167
20100292171
2010-11-18

Competitive Regulation of Hepcidin mRNA by Soluble and Cell-Associated Hemojuvelin

#4168
20100292168
2010-11-18

Protein Mixture and Use Thereof in the Preparation of a Product that is Intended for Oral or Enteral Administration

#4169
20100292149
2010-11-18

Modulation of the Neuroendocrine System as a Therapy for Motor Neuron Disease

#4170
20100291677
2010-11-18

REDUCER OF IMMUNOSUPPRESSION BY TUMOR CELL AND ANTITUMOR AGENT USING THE SAME

#4171
20100291064
2010-11-18

Compounds and methods for the treatment of vascular disease

#4172
20100291028
2010-11-18

Method of treating peripheral vascular diseases using IL-18 inhibitors

#4173
20100286141
2010-11-11

Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways

#4174
20100286054
2010-11-11

Myelin basic protein peptide composition

#4175
20100286052
2010-11-11

Use of antisecretory factor

#4176
20100286021
2010-11-11

Methods of Modulating Prokineticin 2 for Treatment of Stress Response and Anxiety-Related Disorders

#4177
20100286020
2010-11-11

MILK PROTEIN COMPOSITION AND USE THEREOF

#4178
20100285031
2010-11-11

Hox Compositions and Methods

#4179
20100279927
2010-11-04

Method of treating a disease or condition characterized by aberrant epithelial cell proliferation

#4180
20100273174
2010-10-28

Antibodies to tumor associated proteins

#4181
20100272737
2010-10-28

Voltage gated calcium channel β-subunit anchoring regulator protein and uses thereof

#4182
20100272710
2010-10-28

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING AGING-ASSOCIATED DISEASES

#4183
20100272686
2010-10-28

Oncolytic virus

#4184
20100272646
2010-10-28

Method for inducing lymphoid tissue and modulating intestinal homeostasis

#4185
20100267631
2010-10-21

Apolipoprotein A-I mimics

#4186
20100267620
2010-10-21

METHODS FOR SLOWING SENESCENCE AND TREATING AND PREVENTING DISEASES ASSOCIATED WITH SENESCENCE

#4187
20100266619
2010-10-21

Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereof

#4188
20100266577
2010-10-21

Method of Cancer Treatment with Antagonists of FAS Inhibitors

#4189
20100261657
2010-10-14

Use of a granulin or a granulin-like compound in the therapy or prophylaxis of chronic pains

#4190
20100260755
2010-10-14

IBUDILAST AND IMMUNOMODULATORS COMBINATION

#4191
20100260732
2010-10-14

ROLE FOR SRY IN PARKINSON'S DISEASE

#4192
20100256643
2010-10-07

Methods and kits for treating fractures with a biological agent

#4193
20100256073
2010-10-07

THERAPEUTIC AGENT COMPRISING LIPOCALIN 2 AGAINST CANCER METASTASIS, AND METHODS OF EARLY DIAGNOSIS AND INHIBITION OF CANCER METASTASIS USING LIPOCALIN 2

#4194
20100256059
2010-10-07

Regulation of immune responses by modulation of the function of antigen presenting cells

#4195
20100255579
2010-10-07

TUMOR ANTIGEN PROTEIN AND USE THEREOF

#4196
20100255081
2010-10-07

Method for treating symptoms of diabetes

#4197
20100255041
2010-10-07

Remedy for the treatment of cardio-vascular diseases or disorders

#4198
20100254970
2010-10-07

NGAL for reduction and amelioration of ischemic and nephrotoxic injuries

#4199
20100249040
2010-09-30

Alpha-fetoprotein peptides and uses thereof

#4200
20100247516
2010-09-30

Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof